AstraZeneca Canada Inc. reported 4 lobbying communications with federal officials between Jul 9, 2026 and Jul 17, 2026.
Officials contacted: David Bredin (Director of Parliamentary Affairs); Elizabeth Wong (Senior Policy Advisor); Eric Costen (Deputy Secretary to the Cabinet (Operations)); Mackenzy Metcalfe (Policy Advisor); Olesia Bissett (Analyst); Raquel Dancho (Member of Parliament).
On the agenda: Policy measures to ensure security of drug supply in Canada and preserve Canada�s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations; Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes; Engage with Canadian government officials to discuss and provide input on Canada�s countermeasures and policies in response to foreign tariffs affecting the pharmaceutical industry, as well as free trade agreements as they relate to the biopharmaceutical industry.
